ESMO-IO 2020: Circulating Tumor DNA Predicts Response to Atezolizumab in Muscle-Invasive Urothelial Carcinoma
Findings help identify patients who could be spared adjuvant therapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.